The FDA has granted clearance to Neuspera Medical for its novel implantable system to treat chronic peripheral nerve pain.
According to a press release from Neuspera, the system comprises a micro-implant that delivers wireless neurostimulation therapy through a wearable transmitter and iPad-based clinician programmer. The ultra-miniaturized system is 75 times smaller than the smallest implantable pulse generators available and provides deeper anatomical targets compared with current technologies.
“The Neuspera ultra-miniaturized system has the potential to revolutionize the way physicians